First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French hospital.
Ploy
M C
MC
Grélaud
C
C
Martin
C
C
de Lumley
L
L
Denis
F
F
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D016106:Methicillin Resistance; D008826:Microbial Sensitivity Tests; D009894:Opportunistic Infections / Q000188:drug therapy*; D018805:Sepsis / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000187:drug effects*; D014640:Vancomycin / Q000009:adverse effects / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D014640:Vancomycin